LEGN
Legend Biotech Corp
$39.75
Earnings Summary
Revenue | $160.21Mn |
Net Profits | $-125.32Mn |
Net Profit Margins | -78.23% |
Highlights
Legend Biotech Corp’s revenue jumped 66.86% since last year same period to $160.21Mn in the Q3 2024. On a quarterly growth basis, Legend Biotech Corp has generated -14.11% fall in its revenue since last 3-months.
Legend Biotech Corp’s net profit fell -101.46% since last year same period to $-125.32Mn in the Q3 2024. On a quarterly growth basis, Legend Biotech Corp has generated -588.73% fall in its net profits since last 3-months.
Legend Biotech Corp’s net profit margin fell -20.74% since last year same period to -78.23% in the Q3 2024. On a quarterly growth basis, Legend Biotech Corp has generated -701.87% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Legend Biotech Corp post its latest quarter earnings
EPS Estimate Current Quarter | -0.42 |
EPS Estimate Current Year | -0.42 |
Highlights
Legend Biotech Corp’s earning per share (EPS) estimates for the current quarter stand at -0.42 - a -10.53% fall from last quarter’s estimates.
Legend Biotech Corp’s earning per share (EPS) estimates for the current year stand at -0.42.
Key Ratios
Key ratios of the Legend Biotech Corp post its Q3 2024 earnings
Earning Per Share (EPS) | -0.68 |
Highlights
Legend Biotech Corp’s earning per share (EPS) fell -101.12% since last year same period to -0.68 in the Q3 2024. This indicates that the Legend Biotech Corp has generated -101.12% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-12 | -0.42 | -0.68 | -62.81% |
2024-08-09 | -0.38 | -0.1 | 73.68% |
2024-05-13 | -0.34 | -0.16 | 52.94% |
₹0 US Stocks a/c Opening Fee